title: [Baboon syndrome].
authors: Erwan
authors: E
authors: Oehler
authors: Sassan
authors: S
authors: Eftekari-Hassanlouie
authors: Aurore
authors: A
authors: Le Guern
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D004359:Drug Therapy, Combination; D004890:Erythema / Q000139:chemically induced; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019365:Metaphor; D010215:Papio; D025762:Pristinamycin / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D013577:Syndrome; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D006633:Histamine Antagonists; D025762:Pristinamycin